Sales and storage of Schedule 1 precursors—the Act, s 45(2A)
5 Sales and storage of Schedule 1 precursors—the Act, s 45(2A)
A person (the supplier) must not supply a Schedule 1 precursor to a person (the receiver) unless the receiver—
has an account with the supplier and payment for the supply is made through the account, and
has provided the supplier with an end user declaration at least 24 hours before the supply, and
has provided the supplier with proof of the receiver’s identity at least 24 hours before the supply.
A supplier of a Schedule 1 precursor must store the precursor in a way that prevents a person accessing the precursor if the person is not—
the supplier, or
a person who has the supplier’s written authorisation to access the precursor.
A supplier who gives a person written authorisation to access a Schedule 1 precursor must—
make the authorisation available for inspection during business hours on request by a police officer, and
keep a copy of the authorisation for at least 2 years after it ceases to have effect.
A supplier who supplies a Schedule 1 precursor to a receiver must record—
the name and quantity of the Schedule 1 precursor supplied, and
the date of supply of the Schedule 1 precursor from the supplier’s premises.
A supplier must—
make the following available for inspection during business hours on request by a police officer—
each end user declaration provided to the supplier by a receiver,
each record made by the supplier, and
keep each declaration and record for at least 2 years.
Subsections (1), (3) and (4) do not apply to the supply of Ephedrine, Phenylpropanolamine or Pseudoephedrine or a salt of Ephedrine, Phenylpropanolamine or Pseudoephedrine if—
the substance is supplied for therapeutic use within the meaning of the relevant therapeutic goods laws, and
the substance is packaged and labelled in accordance with the relevant therapeutic goods laws, and
the supplier is authorised, by the relevant therapeutic goods laws, to supply the substance.
In this section—
end user declaration means a document, completed by a receiver of a Schedule 1 precursor, specifying the following—
the name and address of the receiver,
details of the receiver’s proof of identity provided to the supplier,
the name and quantity of the Schedule 1 precursor to be supplied,
the proposed date of supply of the Schedule 1 precursor from the supplier’s premises,
the intended use for the Schedule 1 precursor.
relevant therapeutic goods laws means—
the Poisons and Therapeutic Goods Act 1966, and
the regulations under that Act, and
the Commonwealth therapeutic goods laws within the meaning of that Act as the laws apply as a law of this State.
Schedule 1 precursor means a substance listed in Schedule 1 but, unless specified in Schedule 1, does not include—
a preparation, admixture, salt, isomer, ester or ether of a substance listed in Schedule 1, or
a salt of an isomer, ester or ether of a substance listed in Schedule 1.
Maximum penalty—
for a corporation—100 penalty units for a first offence or 150 penalty units for a second or subsequent offence, or
for an individual—30 penalty units for a first offence or 50 penalty units for a second or subsequent offence.
Sign in to see bill, explanatory material, and regulations and instruments
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.